Tyers Asset Management LLC grew its position in Acadia Healthcare Company Inc (NASDAQ:ACHC) by 31.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,904 shares of the company’s stock after buying an additional 1,424 shares during the quarter. Tyers Asset Management LLC’s holdings in Acadia Healthcare were worth $193,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of ACHC. Freshford Capital Management LLC acquired a new stake in shares of Acadia Healthcare in the fourth quarter valued at $31,835,000. Frontier Capital Management Co. LLC grew its stake in shares of Acadia Healthcare by 13.2% in the fourth quarter. Frontier Capital Management Co. LLC now owns 2,903,403 shares of the company’s stock valued at $94,738,000 after buying an additional 337,961 shares in the last quarter. Sapience Investments LLC acquired a new stake in shares of Acadia Healthcare in the fourth quarter valued at $10,279,000. Aristotle Capital Management LLC grew its stake in shares of Acadia Healthcare by 5.0% in the fourth quarter. Aristotle Capital Management LLC now owns 6,183,866 shares of the company’s stock valued at $201,780,000 after buying an additional 297,069 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of Acadia Healthcare by 11.8% in the third quarter. Dimensional Fund Advisors LP now owns 1,662,663 shares of the company’s stock valued at $79,408,000 after buying an additional 176,020 shares in the last quarter.
A number of brokerages have recently weighed in on ACHC. Royal Bank of Canada reaffirmed a “buy” rating and issued a $45.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, February 27th. BidaskClub raised Acadia Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, February 22nd. Jefferies Group set a $42.00 price objective on Acadia Healthcare and gave the company a “buy” rating in a research note on Tuesday, December 19th. Robert W. Baird set a $42.00 target price on Acadia Healthcare and gave the stock a “hold” rating in a research note on Thursday, February 22nd. Finally, Credit Suisse Group reissued a “neutral” rating and set a $40.00 target price (up from $35.00) on shares of Acadia Healthcare in a research note on Thursday, February 22nd. Six research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $44.50.
Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, February 21st. The company reported $0.61 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.54 by $0.07. The firm had revenue of $724.50 million during the quarter, compared to analysts’ expectations of $713.20 million. Acadia Healthcare had a return on equity of 8.16% and a net margin of 6.92%. Acadia Healthcare’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.59 EPS. analysts anticipate that Acadia Healthcare Company Inc will post 2.45 earnings per share for the current fiscal year.
In other Acadia Healthcare news, VP Randall P. Goldberg sold 960 shares of Acadia Healthcare stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $38.47, for a total transaction of $36,931.20. Following the completion of the sale, the vice president now directly owns 6,942 shares of the company’s stock, valued at approximately $267,058.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Reeve B. Waud sold 7,698 shares of Acadia Healthcare stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $42.03, for a total value of $323,546.94. Following the sale, the director now directly owns 10,088 shares of the company’s stock, valued at $423,998.64. The disclosure for this sale can be found here. Insiders have sold a total of 401,360 shares of company stock valued at $15,759,096 over the last ninety days. 11.10% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: This news story was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3296939/tyers-asset-management-llc-raises-stake-in-acadia-healthcare-company-inc-achc.html.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.